Abstract
The etonogestrel implant, Implanon® is a sterile 4-cm × 2-mm single rod that is implanted subdermally and can provide up to 3 years of continuous effective contraception. Each rod contains 68 mg of the progestin etonogestrel encased in an ethylene vinylacetate copolymer skin [1]. It is supplied in a sterile, preloaded disposable applicator. The applicator greatly facilitates proper insertion in a superficial plane, reduces the risk of infection via contamination of the sterile rod, and allows insertion without the need for incision and concomitant risk of scarring. Implanon® was approved by the US Food and Drug Administration in July 2006, but has already been used by over 5 million women worldwide.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Implanon® package insert. Organon USA Inc; Roseland, NJ; July 2006.
Levine JP. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences. J Fam Pract 2004;53(11):904–913.
Amer College of Obstetricians and Gynecologists. ACOG Practice Bulletin No 73. Obstet Gynecol 2006;107:1453–1472.
Wechselberger G, Wolfram D, Pulzl P, Soelder E, Schoeller T. Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol 2006;195(1):323–326.
Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2007;(3):CD001326.
Mascarenhas L. Insertion and removal of Implanon®. Contraception 1998;58(6 suppl):79S–83S.
Klavon SL, Grubb GS. Insertion site complications during the first year of Norplant® use. Contraception 1990;41(1):27–37.
Dunson TR, Amatya RN, Krueger SL. Complications and risk factors associated with the removal of Norplant® implants. Obstet Gynecol 1995;85(4):543–548.
Shulman LP, Gabriel H. Management and localization strategies for the nonpalpable implanon® rod. Contraception 2006;73(4):325–330.
Additional Resources Articles
Levine JP. Insertion and removal of the single-rod progestin-only contraceptive implant. Female Patient 2006;suppl:26–30.
Web Sites
Information about insertion and removal of Implanon® is available from the manufacturer by contacting Organon USA Inc at 1-877-467-5266 or www.implanon-usa.com.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Implanon® is a registered trademark of Schering-Plough (Merck & Co., Inc., Whitehouse Station, NJ).
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Levine, J.P. (2010). Implanon®: Insertion and Removal. In: Sulik, S., Heath, C. (eds) Primary Care Procedures in Women's Health. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76604-1_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-76604-1_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-76598-3
Online ISBN: 978-0-387-76604-1
eBook Packages: MedicineMedicine (R0)